Teva Misses 2Q17 Estimates, Slashes FY17 View

Lack of an experienced permanent CEO continues to haunt the world’s largest drug maker Teva Pharmaceutical Industries Ltd (NYSE: TEVA), which reported a decline in the fiscal 2017 second-quarter results compared to the second-quarter of 2016. The company also missed the earnings and revenue Consensus estimates of analysts. Considering the planned job cuts, retreat from […]

Microsoft Beats 4Q17 View, Azure Grows 97% y-o-y

The software behemoth Microsoft Corp (NASDAQ: MSFT) reported its fiscal 2017 fourth-quarter results last week. The company exceeded expectations across all segments. In particular, revenues from the cloud computing platform Azure grew 97% on y-o-y basis. Microsoft also provided an impressive fiscal 2018 first-quarter outlook. Thus, we anticipate the stock, which closed at $73.04, to […]

Pepsi Beats Q2 Estimates, Raises FY17 EPS View

The world’s second largest beverage company PepsiCo Inc. (NYSE: PEP) reported better than expected revenues and earnings in its second-quarter of fiscal 2017. The company also raised its fiscal 2017 earnings outlook. On the basis of efforts taken by the company to increase margins, offset falling demand for fizzy drinks and remain on a growth […]